Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
55 Cards in this Set
- Front
- Back
blood agar
|
1. charact: sheep blood, general purpose to isolate
2. differential-hemolysis pattern can aid in identification |
|
chocolate agar
|
1. description: plate of blood that was heated to to lyse RBCs, providing extra nutrients.
2. Good to grow Haemophilus and Neisseria |
|
Thayer-Martin
|
1. chocolate agar with antibiotics to select for N. gonorrhoeae
|
|
Mannitol-salt agar
|
1. High salt content
2. prevents all but S. aureus that grows, agar goes from pink to yellow |
|
MacConkey agar
|
1. bile salts and crystal violet agar
2. selects for Gram (-). 3. inhibits Gram (+) and some Gram (-) like Hemophilus and Neisseria. 4. Lactose is the sole carb, if fermented, agar turns pink |
|
Eosin Methylene Blue (EMB) agar
|
1. similar to MacConkey, but with eosin and methylene blue dyes.
2. Lactose fermentors can show blue-black or have a metallic sheen |
|
Bile esculin agar
|
1. bile salts
2. inhibit Gram (+) and most strep 3. selects for Group D Strep and Enterococcus. Seen by black precipitate |
|
Hektoen enteric (HE) agar
|
1. Bile salts and indicator dyes
inhibits the growth of Gram (+). isolation of enteric pathogens fermentor of lactose, sucrose, or salin appear yellow, bact that can produce H2S (ex: Salmonella) will form black precipitate |
|
Cetramide agar
|
contain cetrimide, that acts as a detergent
inhibits most bact selective and differential for Pseudomonas aeruginosa that show blue-green when positive |
|
Tellurite agar (cystine-tellurite agar)
|
potassium tellurite
inhibits Gram (-) and most upper resp bact selective and differential for Corynebacterium diphtheriae that appear grey/black with brown halo |
|
Chromogenic agar
|
selective and differential for diff bact, designed for certain bact. These can be Listeria monocytogenes, S. aureus, MRSA
|
|
catalase test
|
detects catalase that can convert H2O2 to water and O2. Rapid test, minutes
|
|
coagulase
|
detects coagulase enzyme that converts fibrinogen to fibrin. S. aureus and Y. pestis are positive. Rapid (overnight)
|
|
Fermenation
|
pH indicator detects fermentation of sugar in meduim
|
|
Oxidase
|
detects presence of cyctochrome oxidase, changes from clear to pink/purple
|
|
Urease
|
detects presence of urease that breaks down amides and turns a pH indictaor
|
|
Thioglycollate
|
thioglycollate removes oxygen, so a tube can have an O2 gradient, showing growth in relation to O2
|
|
alpha hemolysis
|
discoloration of agar, bact is making H2O2 that is oxidizing the Hb, changing the color
|
|
beta hemolysis
|
complete lysis of the RBCs
|
|
gamma hemolysis
|
no hemolysis, just growth on the plate
|
|
Specimen label must include…
|
Pt name, ID #, specimen source, ordering physician, date/hour collected
|
|
Sterile body sites (normally)
|
blood, marrow, CSF, serous fluids, tissues, lower resp tract, bladder
|
|
non-sterile body sites (normally have commensal flora)
|
mouth, nose, upper resp tract, skin, GI tract, female genital tract, urethra
|
|
Western Blot is detecting this
|
antibodies to the antigen
|
|
When to use/avoid culture as a tech
|
Use: easy to grow/identify the bact or fungi, to use antimicrobial susceptibility test
Avoid: does not grow, extremely infectious or dangerous |
|
When to use/avoid microscopy
|
Use: when staining properities are useful and organism can be identified by morphology
|
|
When to use antigen detection
|
when antigen is in high amounts for detection, when rapid assay is useful
|
|
When to use microbial nucleic acid test
|
they are very sensitive/specific, when feasible/affordable. Good for viruses and other obligate intracellular organisms as well as tracking viral loads
|
|
When to use serology tests
|
organisms that are hard/dangerous to cultivate, tracking a pt's course of illness or immune status, but take a long time (a week or more), might not be positive in immunocompromised in pts, hard to interpret past exposure from current infection
|
|
drug idiosyncrasy
|
a genetically determined, abnormal reactivity to a drug
|
|
Drug idiosyncrasy w/ chloramphenicol
|
aplastic anemia
|
|
Drug idiosyncraasy w/phenytoin, barbiturates, ethanol, estrogens
|
porphyrias (acute intermittent, variegate)
|
|
drug idiosyncrasy w/ isoniazid
|
neurotoxicity
|
|
drug idiosyncracy w/ general anesthetics
|
malignant hyperthermia
|
|
allergy type 1
|
"Immediate rxns", mediated by IgE, 1st exposure provokes production of IgE on mast cells, 2nd exposure An/Ab binding is large release of inflammatory mediators.
Ex: anaphylaxis, allergic asthma, allergic rhinitis, etc |
|
allergy type 2
|
"antibody-dependent cytotoxicity". Mediated by IgG or IgM. Foreign components stick to self cell, invoking the immune response to kill it.
Ex: lupoid syndrome, some hemolytic anemia |
|
allergy type 3
|
"immune complex-mediated rxn". Mediated by IgG or IgM. Excess An/Ab complexes not cleared my macrophages form deposits on blood vessel walls eliciting inflammation.
Ex: serum sickness, some forms of hepatitis, nephritis, arthritis |
|
allergy type 4
|
"delayed or cell-mediated rxn". Sensitized T-cells react to antigen to produce edema and inflammation.
Ex: contact dermatitis, erythema multiforme |
|
pseudoalleric rxn
|
allergic like rxn, but no circulating Ab can be found. Due to direct release of histamine or other mediators by a drug. Mimics true anaphylaxis, except that the rxn is dose dependent.
|
|
Fetus stage: blastogenesis. Timeframe and effect on fetus by drugs
|
0-16 days, either no effect or abortion
|
|
Fetus stage: organogenesis. Timeframe and effect on fetus by drugs
|
17-80 days, abortion/functional defects are low, malformations are high risk
|
|
Fetus stage: Histogenesis and functional development. Timeframe and effect on fetus by drugs
|
81 days to term, abortion/malformations low risk, metabolic or functional defects at med to high risk
|
|
FDA Category A drug
|
Well controlled studies show no apparent risk to humans
|
|
FDA Category B drug
|
Animal studies show no risk but no adequate studies in humans
|
|
FDA Category C drug
|
Animal studies do show risk but no adequate studies in humans
|
|
FDA Category D drug
|
There is a positive evidence of human risk, but benefits may warrant the risk. Therefore BAD for preg!!
|
|
FDA Category X drug
|
Positive data exist and risks outweigh benefits. Therefore BAD for preg!!
|
|
Drugs proven or highly suspected to be carcinogenic (7 drugs)
|
antineoplastics, estrogens, androgens, alcohol, phenacetin, phenytoin, chloramphenicol
|
|
Drug misuse
|
Any use of a drug for medical purposes but for the wrong indication,in the wrong dosage, for too long a period, etc.
|
|
drug abuse
|
Any use of a drug for non medical purposes (altering consciousness,body-building, etc.)
|
|
drug dependence
|
a state, psychic and sometimes physcial, resulting from an interaction between a living organism and a drug, charact by behav and other responses that always include a compulsion to take the drug on a continuous or periodic basis in oder to experience its psychic effects and sometimes to avoid the discomfort of its absence. (WHO 1969)
|
|
drug addiction
|
The term has been used in so many ways that it can no longer beemployed without further qualification.
|
|
side effect of a drug
|
an unitnteded non-deleterious drug effect occurring after admin of doses normally used in humans and related to the pharm properties of the drug
|
|
theraputic window of a drug
|
the interval between the minium therapeutic conc and the minimum toxic conc of the drug
|
|
therapeutic index
|
several calculations, changing with confidence.
LD50/ED50 TD50/ED50, TD1/ED99. TD=toxic dose, ED=effective dose |